These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 909051)
1. Temporal pattern and reversal of impaired hepatic mono-oxygenases by phenobarbital in rats with developing and established adjuvant disease. Mathur PP; Smyth RD; Witmer CM; Carr GS; Reavey-Cantwell NH J Pharmacol Exp Ther; 1977 Oct; 203(1):169-83. PubMed ID: 909051 [No Abstract] [Full Text] [Related]
2. [The effect of adjuvant arthritis on the properties of the liver mono-oxygenase system in the rat]. KamenĂková L; Elis J Cesk Farm; 1981 Nov; 30(9):290-3. PubMed ID: 7317952 [No Abstract] [Full Text] [Related]
3. Effects of a nonsteroidal anti-inflammatory agent and phenobarbital on hepatic microsomal mono-oxygenases in adjuvant disease in the rat. Mathur PP; Smyth RD; Witmer CM; Carr GS Biochem Pharmacol; 1978; 27(13):1771-4. PubMed ID: 708458 [No Abstract] [Full Text] [Related]
4. Effect of 7 8-benzoflavone on the duration of zoxazolamine paralysis and hexobarbital hypnosis in rats. Wiebel FJ; Waters HL; Elliot S; Gelboin HV Biochem Pharmacol; 1976 Jun; 25(12):1431-2. PubMed ID: 938565 [No Abstract] [Full Text] [Related]
5. Hexobarbital sleeping time and drug metabolism in rats with ligated bile ducts--a lack of correlation. Drew R; Priestly BG Biochem Pharmacol; 1976 Jul; 25(14):1659-63. PubMed ID: 942466 [No Abstract] [Full Text] [Related]
6. [Inhibition of the cytochrome P-450-dependent monooxygenase system of the liver in rats with adjuvant arthritis]. Kovalev IE; Kosheleva NA; Khlopushina TG; Lysenkova EM; Pautova IG Patol Fiziol Eksp Ter; 1983; (4):29-31. PubMed ID: 6634222 [No Abstract] [Full Text] [Related]
7. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice. Murphy JP; Van Stee EW; Back KC Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555 [No Abstract] [Full Text] [Related]
8. Inductive effects of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane(DDT), phenobarbital, and benzpyrene on microsomal cytochrome B450, ethyl isocyanide spectra, and metabolism in vivo of zoxazolamine and hexobarbital in the mouse. Abernathy CO; Philpot RM; Guthrie FE; Hodgson E Biochem Pharmacol; 1971 Sep; 20(9):2395-400. PubMed ID: 5163150 [No Abstract] [Full Text] [Related]
9. Interaction between cadmium and phenobarbital on the activity of the hepatic microsomal monooxygenase system in the male rat. Means JR; Schnell RC Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):187-90. PubMed ID: 7360999 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms in the potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol. Yasaka WJ; Sasame HA; Saul W; Maling HM; Gillette JR Biochem Pharmacol; 1978; 27(24):2851-8. PubMed ID: 736977 [No Abstract] [Full Text] [Related]
11. Destruction of endogenous and exogenous haem by 2-allyl-2-isopropylacetamide: role of the liver cytochrome P-450 which is inducible by phenobarbitone. Unseld A; de Matteis F Int J Biochem; 1978; 9(12):865-9. PubMed ID: 744288 [No Abstract] [Full Text] [Related]
12. [Effect of dietary iron deficiency on the activity of the monooxygenase system of rat liver microsomes and its induction by phenobarbital]. Lashneva NV Vopr Pitan; 1982; (3):26-9. PubMed ID: 7113097 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relations for methylenedioxyphenyl and related compounds on hepatic microsomal enzyme function, as measured by prolongation of hexobarbital narcosis and zoxazolamine paralysis in mice. Fujii K; Jaffe H; Bishop Y; Arnold E; Mackintosh D; Epstein SS Toxicol Appl Pharmacol; 1970 Mar; 16(2):482-94. PubMed ID: 5435617 [No Abstract] [Full Text] [Related]
14. A role of the dietary lipid in the ability of phenobarbital to stimulate drug detoxification. Century B J Pharmacol Exp Ther; 1973 May; 185(2):185-94. PubMed ID: 4703818 [No Abstract] [Full Text] [Related]
15. Polychlorinated biphenyls: comparative effects of high and low chlorine containing Aroclors on hepatic mixed function oxidase. Bickers DR; Harber LC; Kappas A; Alvares AP Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):505-12. PubMed ID: 4624582 [No Abstract] [Full Text] [Related]
16. Effect of pretreatment of rabbits with phenobarbital or 3-methylcholanthrene on the distribution of drug-metabolizing enzyme activity in subfractions of hepatic microsomes. Gram TE; Rogers LA; Fouts JR J Pharmacol Exp Ther; 1967 Aug; 157(2):435-45. PubMed ID: 6039834 [No Abstract] [Full Text] [Related]
17. Studies on drug metabolism and liver ultrastructure after conjoint treatment with pregnenolone-16alpha-carbonitrile and dl-ethionine. Garg BD; Kourounakis P; Tuchweber B; Szabo S; Kovacs K Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):283-93. PubMed ID: 907413 [TBL] [Abstract][Full Text] [Related]
18. Effects of furazolidone on duration of righting reflex loss induced with hexobarbital and zoxazolamine in the rat. Sasaki N J Vet Med Sci; 1994 Aug; 56(4):667-70. PubMed ID: 7999888 [TBL] [Abstract][Full Text] [Related]
19. Aryl 4-hydroxylase, cytochrome P-450 and microsomal lipids in essential fatty acid deficiency. Kaschnitz R Hoppe Seylers Z Physiol Chem; 1970 Jun; 351(6):771-4. PubMed ID: 5425949 [No Abstract] [Full Text] [Related]